Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IKT Net Margin

The Net Margin of Inhibikase Therapeutics Inc (IKT) is -7304.75%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

IKT Net Margin - Historical Value
Date Value
2024-12-31 -7304.75%
2023-12-31 -7304.75%
2022-12-31 -15041.67%
2021-12-31 -477.10%
2020-12-31 -407.14%
2019-12-31 -510.71%
2018-12-31 -53.22%
2017-12-31 -21.36%
2016-12-31 -64.95%
IKT Net Margin - Peers Comparison